Order Article Reprints

Lopez-Millan B, Costales P, Gutiérrez-Agüera F, Díaz de la Guardia R, Roca-Ho H, Vinyoles M, Rubio-Gayarre A, Safi R, Castaño J, Romecín PA, et al. The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia. Cancers. 2022; 14(6):1593. https://doi.org/10.3390/cancers14061593

Lopez-Millan, Belen, Paula Costales, Francisco Gutiérrez-Agüera, Rafael Díaz de la Guardia, Heleia Roca-Ho, Meritxell Vinyoles, Alba Rubio-Gayarre, Rémi Safi, Julio Castaño, Paola Alejandra Romecín, and et al. 2022. "The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia" Cancers 14, no. 6: 1593. https://doi.org/10.3390/cancers14061593

Lopez-Millan, B., Costales, P., Gutiérrez-Agüera, F., Díaz de la Guardia, R., Roca-Ho, H., Vinyoles, M., Rubio-Gayarre, A., Safi, R., Castaño, J., Romecín, P. A., Ramírez-Orellana, M., Anguita, E., Jeremias, I., Zamora, L., Rodríguez-Manzaneque, J. C., Bueno, C., Morís, F., & Menendez, P. (2022). The Multi-Kinase Inhibitor EC-70124 Is a Promising Candidate for the Treatment of FLT3-ITD-Positive Acute Myeloid Leukemia. Cancers, 14(6), 1593. https://doi.org/10.3390/cancers14061593